UK accelerates COVID booster plans in response to OmicronThe UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of Share XUK accelerates COVID booster plans in response to Omicronhttps://pharmaphorum.com/news/uk-accelerates-covid-booster-plans-in-response-to-omicron/
Health literacy for the intellectually disabled: is pharma doing enough?What is health literacy and why is it important? Health literacy (HL), defined by the CDC as the Share XHealth literacy for the intellectually disabled: is pharma doing enough?https://deep-dive.pharmaphorum.com/magazine/patients-partnerships/prime-global-health-literacy-intellectually-disabled-pharma/
Leveraging real-world data to meet payers’ needsPayers are becoming savvier in accepting real-world data. Certara’s Lee Stern and Shawn Bates discuss the challenges and Share XLeveraging real-world data to meet payers’ needshttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/real-world-data-meet-payers-needs-certara/
Time for change: PhRMA survey shows insurance creates barriers to healthcare in USHealth insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, Share XTime for change: PhRMA survey shows insurance creates barriers to healthcare in UShttps://pharmaphorum.com/patients/phrma-survey-insurance-creates-barriers-to-healthcare-in-us/
Time for a new model in patient accessMig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is Share XTime for a new model in patient accesshttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/astellas-new-model-patient-access/
EU authorises first COVID-19 vaccine for 5 to 11 year oldsThe European Medicines Agency (EMA) has approved Pfizer and BioNTech’s COVID-19 vaccine Comirnaty for children between the ages Share XEU authorises first COVID-19 vaccine for 5 to 11 year oldshttps://pharmaphorum.com/news/eu-approves-first-covid-19-vaccine-for-5-to-11-year-olds/
New COVID variant ‘may sidestep vaccine protection’A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears Share XNew COVID variant ‘may sidestep vaccine protection’https://pharmaphorum.com/news/new-covid-variant-may-sidestep-vaccine-protection/
Time to take patient engagement to the next levelPatient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn Share XTime to take patient engagement to the next levelhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/envision-pharma-patient-engagement/
UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer firstGenomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for Share XUK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer firsthttps://pharmaphorum.com/patients/public-approval-whole-genome-sequencing-newborn-screenings-uk-wide-rollout/
